Kiora Pharmaceuticals, Inc. Common Stock (KPRX) is a publicly traded Healthcare sector company. As of August 7, 2026, KPRX trades at $2.59 with a market cap of $11.26M and a P/E ratio of -0.98. KPRX moved +1.13% today. Year to date, KPRX is +26.73%; over the trailing twelve months it is +5.35%. Its 52-week range spans $1.76 to $4.18. Analyst consensus is buy with an average price target of $12.00. Rallies surfaces KPRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for KPRX, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $2.59 |
| Market Cap | $11.26M |
| P/E Ratio | -0.98 |
| EPS | $-2.60 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.18 |
| 52-Week Low | $1.76 |
| Volume | 462 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-10.84M |
| Gross Margin | 0.00% |
1 analysts cover KPRX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.00.